In 2013, a small group of technocrats with deep experience in biotechnology and a shared frustration with a systemic gap in reagent quality came together with a mission: to change how lifesaving biology is supported at its roots. That was the beginning of deNOVO Biolabs. Born from curiosity, necessity, and a deep commitment to enabling reliable science.
The Vision
deNOVO was started by scientists who had seen firsthand the impact of inconsistent reagents, unvalidated assays, and lack of locally developed tools on real research and development programs. Inspired by initiatives like BIRAC and the Vision Group of Karnataka, the founders envisioned an Indian biotech company that could deliver world-class reagents and services with global standards.
From the outset, the goal was clear:
to empower researchers, diagnostic developers, and biopharma innovators with tools that they can trust for consistent, reproducible outcomes.
The Gap
Traditional laboratory reagents and immunoassay tools were often sourced from multinational suppliers. While these products were trusted, they were not always accessible, affordable, or tailored to local needs. Moreover, many emerging labs and biosimilar developers lacked access to products and expertise that met both regulatory expectations and real-world application requirements.
That’s why deNOVO chose to focus on areas that truly matter:
- ELISA kits for pharmacokinetics and immunogenicity — foundational tools in biosimilar development
- Custom antibodies and recombinant proteins to serve both diagnostic and therapeutic pipelines
- Assay reagents and cell culture tools designed with reproducibility in mind
Today, deNOVO stands out as the 1st Indian company to manufacture ELISA kits for PK and immunogenicity widely used by leading biosimilar developers.
Built on Quality, Driven by Innovation
From the beginning, quality was a commitment. deNOVO’s founders knew that trust in science starts with tools that perform reliably across batches, conditions, and applications. This ethos is reflected in every product and service, backed by industry certifications such as ISO 9001:2015 and ISO 13485:2016, state-of-the-art facilities, and a scientific team dedicated to excellence.
The company’s capabilities today span:
- Custom antibody development
- Cell-based and molecular assays
- Recombinant proteins and assay reagents
- PK/ADA ELISA kits and diagnostic antibodies
- Gene synthesis, protein expression, and assay validation support
These offerings reflect a deep understanding of what scientists and developers truly need.
Commitment to Accessibility & Innovation
deNOVO’s founding was also influenced by a strong belief in “Make in India” and Atmanirbhar Bharat initiatives. To build indigenous capacity that reduces dependency on imports while meeting global quality standards.
This vision goes beyond supplying reagents; it means giving researchers and developers access to tools that help them compete internationally without compromising on quality or timeline.
The Future
A decade on, deNOVO continues to evolve with its partners — whether they’re academic researchers navigating funding pressures or biopharma teams pushing complex biologics into clinical stages. The same founding principles still guide the company:
- Innovation grounded in real scientific need
- Commitment to quality that meets regulatory expectations
- Partnership-driven service that supports lab success
Because science that can be trusted is science that can transform.
Contact Us
If your team is refining immunoassays, scaling biologics, or designing robust analytical methods, we’d love to explore how our tools and expertise can support your goals this year.
Reach out for a technical conversation or customized solution.